Gyre Therapeutics (GYRE) Current Ratio: History & Chart

Gyre Therapeutics, Inc.(GYRE)

Biotechnology · San Diego, CA

$7.18-0.17 (-2.38%)

Delayed quote: Oct 6, 2026, 11:40 AM EDT

About Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials for several other conditions, including dermatomyositis and interstitial lung disease linked to systemic sclerosis, pneumoconiosis, and diabetic kidney disease. The company's pipeline further includes F351 (Hydronidone), a compound structurally related to ETUARY. F351 is currently in Phase 3 studies for chronic hepatitis B-induced liver fibrosis and is in Phase 1 trials for liver fibrosis associated with nonalcoholic associated steatohepatitis (NASH). Other programs in development feature F573, which is progressing through Phase 2 studies for acute and acute-on-chronic liver failure. Additionally, two early-stage candidates, F528 and F230, are in preclinical development, focusing on chronic obstructive pulmonary disease (COPD) and pulmonary arterial hypertension (PAH), respectively. Established in 2002, Gyre Therapeutics, Inc. is based in San Diego, California, and operates as a subsidiary of GNI USA, Inc.

San Diego, CA

625 employees

www.gyretx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ying Luo

View full financials

GYRE Current Ratio Metrics

CURRENT RATIO

4.26

CURRENT RATIO AVG TTM

5.22

CURRENT RATIO AVG 3Y

4.03

CURRENT RATIO AVG 5Y

3.98

CURRENT RATIO AVG 10Y

4.40

CURRENT RATIO AVG 15Y

7.70

CURRENT RATIO AVG 20Y

6.30

CURRENT VS TTM AVG

-18.36%

CURRENT VS 3Y AVG

+5.62%

CURRENT VS 5Y AVG

+7.14%

CURRENT VS 10Y AVG

-3.12%

CURRENT VS 15Y AVG

-44.68%

CURRENT VS 20Y AVG

-32.43%

SECTOR MEDIAN · HEALTHCARE

3.49

median of 705 covered companies

CURRENT VS SECTOR MEDIAN

+22.03%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Gyre Therapeutics, Inc. (GYRE)	$799.93M	4.26	5.22	4.03	3.98
AdaptHealth Corp. (AHCO)vs ›	$796.60M	1.12	1.18	1.21	1.17
Apnimed, Inc. (APMD)vs ›	$804.20M	N/A	N/A	N/A	N/A
InMode Ltd. (INMD)vs ›	$805.59M	8.18	10.05	10.24	9.72
Geron Corporation (GERN)vs ›	$789.07M	6.92	5.11	3.93	4.38
Lexicon Pharmaceuticals, Inc. (LXRX)vs ›	$785.87M	13.37	5.16	5.50	4.90
Ardelyx, Inc. (ARDX)vs ›	$817.22M	3.34	4.45	4.03	4.25
Attovia Therapeutics, Inc. (ATTO)vs ›	$774.92M	9.39	11.79	11.79	11.79
Pacific Biosciences of California, Inc. (PACB)vs ›	$826.20M	4.92	7.19	6.36	8.34
Mesa Laboratories, Inc. (MLAB)vs ›	$773.58M	2.07	1.18	1.89	3.24

NAME

MARKET CAP

CURRENT RATIO

TTM

Gyre Therapeutics, Inc. (GYRE)

$799.93M

4.26

5.22

4.03

3.98

AdaptHealth Corp. (AHCO)vs ›

$796.60M

1.12

1.18

1.21

1.17

Apnimed, Inc. (APMD)vs ›

$804.20M

N/A

InMode Ltd. (INMD)vs ›

$805.59M

8.18

10.05

10.24

9.72

Geron Corporation (GERN)vs ›

$789.07M

6.92

5.11

3.93

4.38

Lexicon Pharmaceuticals, Inc. (LXRX)vs ›

$785.87M

13.37

5.16

5.50

4.90

Ardelyx, Inc. (ARDX)vs ›

$817.22M

3.34

4.45

4.03

4.25

Attovia Therapeutics, Inc. (ATTO)vs ›

$774.92M

9.39

11.79

Pacific Biosciences of California, Inc. (PACB)vs ›

$826.20M

4.92

7.19

6.36

8.34

Mesa Laboratories, Inc. (MLAB)vs ›

$773.58M

2.07

1.18

1.89

3.24

Current Ratio FAQ

What is the current ratio for Gyre Therapeutics, Inc. (GYRE)?

The current ratio for GYRE stock is 4.26.

Is Gyre Therapeutics, Inc.'s current ratio high or low?

The current ratio of 4.26 is in line with its 5-year average of 3.98, near the low end of its 5-year range (2.05–18.86).

What is the TTM average current ratio for Gyre Therapeutics, Inc. (GYRE)?

The TTM average current ratio for GYRE stock is 5.22.

What is the 3Y average current ratio for Gyre Therapeutics, Inc. (GYRE)?

The 3Y average current ratio for GYRE stock is 4.03.

What is the 5Y average current ratio for Gyre Therapeutics, Inc. (GYRE)?

The 5Y average current ratio for GYRE stock is 3.98.

What is the 10Y average current ratio for Gyre Therapeutics, Inc. (GYRE)?

The 10Y average current ratio for GYRE stock is 4.40.

What is the 15Y average current ratio for Gyre Therapeutics, Inc. (GYRE)?

The 15Y average current ratio for GYRE stock is 7.70.

What is the 20Y average current ratio for Gyre Therapeutics, Inc. (GYRE)?

The 20Y average current ratio for GYRE stock is 6.30.

DATE	CURRENT RATIO
2026-06-30	4.26
2026-03-31	4.64
2025-12-31	5.60
2025-09-30	6.19
2025-06-30	5.40
2025-03-31	3.60
2024-12-31	3.32
2024-09-30	3.72
2024-06-30	3.44
2024-03-31	3.22
2023-12-31	2.85
2023-09-30	2.88
2023-06-30	3.30
2023-03-31	2.05
2022-12-31	4.06
2022-09-30	4.06
2022-06-30	18.86
2022-03-31	2.78
2021-12-31	3.63
2021-09-30	4.29
2021-06-30	6.22
2021-03-31	8.22
2020-12-31	5.03
2020-09-30	6.42
2020-06-30	8.88
2020-03-31	9.13
2019-12-31	3.32
2019-09-30	9.82
2019-06-30	15.83
2019-03-31	24.94
2018-12-31	25.83
2018-09-30	40.20
2018-06-30	56.98
2018-03-31	50.15
2017-12-31	4.48
2017-09-30	3.58
2017-06-30	4.23
2017-03-31	1.87
2016-12-31	1.71
2016-09-30	1.59
2016-06-30	1.67
2016-03-31	1.82
2015-12-31	1.82
2015-09-30	1.92
2015-06-30	60.98
2015-03-31	26.96
2014-12-31	37.11
2014-09-30	36.00
2014-06-30	16.52
2014-03-31	9.98
2013-12-31	13.21
2013-09-30	14.76
2013-06-30	19.33
2013-03-31	21.12
2012-12-31	16.54
2012-09-30	15.10
2012-06-30	15.95
2012-03-31	4.70
2011-12-31	2.53
2011-09-30	2.93
2011-06-30	3.30
2011-03-31	2.50
2010-12-31	2.21
2010-09-30	2.43
2010-06-30	2.54
2010-03-31	3.38
2009-12-31	3.11
2009-09-30	5.80
2009-06-30	5.96
2009-03-31	6.95
2008-12-31	6.67
2008-09-30	6.93
2008-06-30	7.58
2008-03-31	7.17
2007-12-31	6.08
2007-09-30	8.00
2007-06-30	7.98
2007-03-31	10.60
2006-12-31	8.81
2006-09-30	8.49
2006-06-30	9.77
2006-03-31	5.67
2005-12-31	4.94
2005-09-30	0.00
2005-06-30	0.00
2005-03-31	0.00

DATE

CURRENT RATIO

2026-06-30

4.26

2026-03-31

4.64

2025-12-31

5.60

2025-09-30

6.19

2025-06-30

5.40

2025-03-31

3.60

2024-12-31

3.32

2024-09-30

3.72

2024-06-30

3.44

2024-03-31

3.22

2023-12-31

2.85

2023-09-30

2.88

2023-06-30

3.30

2023-03-31

2.05

2022-12-31

4.06

2022-09-30

4.06

2022-06-30

18.86

2022-03-31

2.78

2021-12-31

3.63

2021-09-30

4.29

2021-06-30

6.22

2021-03-31

8.22

2020-12-31

5.03

2020-09-30

6.42

2020-06-30

8.88

2020-03-31

9.13

2019-12-31

3.32

2019-09-30

9.82

2019-06-30

15.83

2019-03-31

24.94

2018-12-31

25.83

2018-09-30

40.20

2018-06-30

56.98

2018-03-31

50.15

2017-12-31

4.48

2017-09-30

3.58

2017-06-30

4.23

2017-03-31

1.87

2016-12-31

1.71

2016-09-30

1.59

2016-06-30

1.67

2016-03-31

1.82

2015-12-31

1.82

2015-09-30

1.92

2015-06-30

60.98

2015-03-31

26.96

2014-12-31

37.11

2014-09-30

36.00

2014-06-30

16.52

2014-03-31

9.98

2013-12-31

13.21

2013-09-30

14.76

2013-06-30

19.33

2013-03-31

21.12

2012-12-31

16.54

2012-09-30

15.10

2012-06-30

15.95

2012-03-31

4.70

2011-12-31

2.53

2011-09-30

2.93

2011-06-30

3.30

2011-03-31

2.50

2010-12-31

2.21

2010-09-30

2.43

2010-06-30

2.54

2010-03-31

3.38

2009-12-31

3.11

2009-09-30

5.80

2009-06-30

5.96

2009-03-31

6.95

2008-12-31

6.67

2008-09-30

6.93

2008-06-30

7.58

2008-03-31

7.17

2007-12-31

6.08

2007-09-30

8.00

2007-06-30

7.98

2007-03-31

10.60

2006-12-31

8.81

2006-09-30

8.49

2006-06-30

9.77

2006-03-31

5.67

2005-12-31

4.94

2005-09-30

0.00

2005-06-30

0.00

2005-03-31

0.00

Current Ratio: 4.26

GYRE Current Ratio

GYRE Average Current Ratio Chart

GYRE Current vs Average Current Ratio Chart

GYRE Current Ratio Metrics

GYRE Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

GYRE Current Ratio History

Related Metrics